- Previous Close
10.51 - Open
10.51 - Bid 10.68 x --
- Ask 10.69 x --
- Day's Range
10.40 - 10.68 - 52 Week Range
9.81 - 13.63 - Volume
4,436,964 - Avg. Volume
4,927,983 - Market Cap (intraday)
10.051B - Beta (5Y Monthly) 0.25
- PE Ratio (TTM)
15.04 - EPS (TTM)
0.71 - Earnings Date --
- Forward Dividend & Yield 0.20 (1.90%)
- Ex-Dividend Date Jul 12, 2024
- 1y Target Est
--
Heilongjiang ZBD Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of Chinese medicines in China. It offers cardiovascular and cerebrovascular, respiratory system, orthopedics, tumors, digestive system, anti-infection, mental nerve, genitourinary, and other disease fields. The company was founded in 1996 and is based in Hulin, China.
www.zbdzy.com2,545
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: 603567.SS
View MorePerformance Overview: 603567.SS
Trailing total returns as of 4/18/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 603567.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 603567.SS
View MoreValuation Measures
Market Cap
10.05B
Enterprise Value
12.45B
Trailing P/E
15.38
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.22
Price/Book (mrq)
1.30
Enterprise Value/Revenue
3.99
Enterprise Value/EBITDA
15.26
Financial Highlights
Profitability and Income Statement
Profit Margin
20.96%
Return on Assets (ttm)
3.55%
Return on Equity (ttm)
8.31%
Revenue (ttm)
3.12B
Net Income Avi to Common (ttm)
653.39M
Diluted EPS (ttm)
0.71
Balance Sheet and Cash Flow
Total Cash (mrq)
966.16M
Total Debt/Equity (mrq)
40.54%
Levered Free Cash Flow (ttm)
-597.32M